Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 10Unknown 4Terminated 4Recruiting 3Withdrawn 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Neoplasms 1Endometrial Hyperplasia 1Anorexia 1

Interventions

pembrolizumab 61Radiotherapy 55Gemcitabine 51Paclitaxel 49Cyclophosphamide 48Cisplatin 48Carboplatin 45Dexamethasone 37Bevacizumab 37Nivolumab 35Fluorouracil 34Docetaxel 34Oxaliplatin 33durvalumab 32Rituximab 28Magnetic Resonance Spectroscopy 28Leucovorin 28Drug Therapy 25Pemetrexed 24Doxorubicin 24Capecitabine 24atezolizumab 22Radiation 20Cytarabine 20Radiosurgery 19Prednisone 19Etoposide 19Irinotecan 17Bortezomib 17Cetuximab 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Withdrawn × Megestrol Acetate × Clear all
NCT01943058 2014-09-10

Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer

University of Southern California

Phase 2 Withdrawn
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT01501396 2014-02-03

Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite

Washington University School of Medicine

Phase 2 Withdrawn

Anorexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡